A Morocco-based gift card fraud campaign is a sign of what retailers can expect this holiday season.
Memento Spyware Tied to Chrome Zero-Day Attacks
While investigating the cyberattacks, researchers uncovered a new spyware product from Memento Labs, the successor to the infamous Hacking Team.
CISOs Finally Get a Seat at the Board’s Table — But There’s a Catch
AI’s explosive growth has lifted cybersecurity to the top of the board’s agenda. Here’s how CISOs can seize the moment, according to Diana Kelley.
Attackers Sell Turnkey Remote Access Trojan ‘Atroposia’
Atroposia, a new RAT malware, offers low-level cybercriminal affiliates the ability to utilize sophisticated stealth and persistence capabilities.
Cigna says it will end drug rebates as pressure mounts on PBMs
Cigna said it will move away from receiving drug rebates, an opaque part of the US drug pricing formula that has drawn increased scrutiny from federal and state lawmakers. The health insurer, which owns pharmacy …
Organon CEO exits after internal probe over ‘channel stuffing’ to boost sales
Organon’s CEO has stepped down and the company’s stock tanked after an internal investigation found evidence of “improper” sales practices for the contraceptive implant Nexplanon. According to the company, the
Eli Lilly teams up with basketball legend Shaquille O’Neal to take sleep apnea awareness campaign to new heights
In Lilly’s new awareness campaign, the NBA legend shares his sleep apnea story and encourages others to discuss their symptoms with a doctor.
Intellia pauses two CRISPR trials after liver toxicity hospitalizes patient
Intellia Therapeutics has paused enrollment and dosing in two clinical trials of its CRISPR therapy, called nex-z, for the genetic disease transthyretin amyloidosis (ATTR), the company announced Monday morning. In a call with investors, CEO …
Verily CEO discusses personal health records launch, spinoff prep
In the last decade, Verily, Alphabet’s life sciences arm, has dabbled in everything from mosquitoes to monitoring wastewater to insurance. But more recently, it’s been — at long last — sharpening its focus and …
FDA names Mary Thanh Hai as permanent director of Office of New Drugs
The FDA last week transitioned Mary Thanh Hai from acting to permanent director of the Office of New Drugs, two people with knowledge of the move told Endpoints News. Thanh Hai took over as acting …